Find clinical trials for Ovarian Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Philadelphia, PA, USA:
the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovaria cancer...
Phase 1
Philadelphia, Pennsylvania, United States and 2 other locations
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...
Phase 2
Philadelphia, Pennsylvania, United States of America and 25 other locations
This study is testing whether a 6 week skills-based telehealth intervention can help ovarian cancer patients experiencing PARP inhi...
Philadelphia, Pennsylvania, United States and 1 other location
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Philadelphia, Pennsylvania, United States and 213 other locations
be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 8 other locations
mirvetuximab soravtansine (MIRV) in patients with platinum resistant ovarian cancer. Approximately 102 patients will be enrolled in...
Phase 1
Philadelphia, Pennsylvania, United States and 23 other locations
and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with mesothelin-expressing advanced ovarian ...
Phase 1
Philadelphia, Pennsylvania, United States and 2 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Philadelphia, Pennsylvania, United States and 176 other locations
Phase 1 trial to study the safety, pharmacokinetic and Preliminary Efficacy of STRO-002 in combination with Bevacizumab.
Phase 1
Philadelphia, Pennsylvania, United States and 5 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Camden, New Jersey, United States of America and 70 other locations
Clinical trials
Research sites
Resources
Legal